Evom AI, a Seoul, South Korea–based medical AI startup developing a cardiology-focused AI platform, has raised a Seed funding round.
Investors
The company previously raised seed funding from Klim Ventures in September 2025 and has now received additional support from Korea’s Ministry of SMEs and Startups through the TIPS Deep Tech program.
Klim Ventures is a Seoul-based early-stage venture capital firm and accelerator. Founded in 2020, the firm focuses on backing ambitious entrepreneurs in sectors like medical AI, deep tech, and SaaS.
The TIPS Deep Tech is a private investment–led tech venture support initiative designed to nurture startups with exceptional technology and talent in strategic sectors.
Evom AI Use of Funds
The company will use the funding to develop AI solutions for the early diagnosis and prediction of cardiovascular diseases, including ECG and echocardiography AI, and to build a large-scale multimodal dataset.
About Evom AI
Founded early last year, Evom AI develops solutions for the early detection, diagnosis, and prevention of cardiovascular diseases. Leveraging proprietary AI model automation and explainable AI frameworks, Evom AI analyzes ECG and echocardiography data, detects subtle signals, automates measurements, and predicts severe cardiac events before they occur. Headquartered in Seoul, South Korea, Evom AI aims to revolutionize medicine with AI-powered proactive and preventive care.
Funding Details
Company: Evom AI, Inc.
Raised: Undisclosed
Round: Seed / Government R&D funding
Funding Date: January 2026
Lead Investor: Klim Ventures
Additional Investors: Korean government via TIPS Deep Tech program
Company Website: https://www.evom.ai/
Software Category: Medical AI / Cardiology AI Platform
Source: https://www.businesskorea.co.kr/news/articleView.html?idxno=260373